AnujParkash Author

Dr Anuj is experienced and trained MD Biochemist, working as consultant in the department of Pathology, RGCI&RC since 2015 with 10+ years of Post-MD experience . He is well experienced in reporting all Biochemistry and Immunoassays with special interest in Oncology chemistry.

IDH Mutations: Game Changer In Glioma Management

Diffuse gliomas are the most common primary brain tumor in adults. While several important genetic alterations in gliomas have been known for some time, deeper genetic and...

Neocytopheresis: New Approach of transfusion in Thalassemia major

Neocytes: These are new red cells which come afresh from bone marrow. They have a longer life span and lesser weight as compared to older cells (gerocytes) in the circulation. The...

Hodgkin Lymphoma and its Differential Diagnosis

Click the following links in succession to read-Hodgkin Lymphoma and Its Differential Diagnosis. Hodgkin Lymphoma and differential diagnosis Part 1 Hodgkin Lymphoma and...

Tisagenlecleucel- Gone are the days of toxic chemotherapy

Cancer is now seen as a disease which arises due to a failure of body immunity to detect the abnormal cells or the cancer cells. With the advancement in the medical science, we...

High Grade B CELL Lymphoma: An Entity In Need Of Clarity

The 2016 classification of lymphoma has introduced a new category of High-Grade B Cell Lymphoma (HGBL) with suggested work up algorithm as shown in Fig1 below. Fig1:  Schema to...

Total Mutation Burden- New Tool for Immunotherapy

Immunotherapy is the new kid off the block and taking long strides.  Many patients with advanced cancer are obtaining durable remissions with this form of therapy. Who will...

Adenosine Triphosphate (ATP): the Universal Energy Currency

The World dabbles extensively in multiple currencies around the world like Dollars, Euros, and Pounds; however one currency which binds us across countries is none other than our...